Latest News

Yale School of Public Health researchers have found that reduced levels of a certain metabolite in younger cancer patients may be associated with early-onset colorectal cancer.

Last week, WHAM (Women’s Health Access Matters) announced the 10 recipients of the 2025 WHAM Edge Awards. Two Yale postdoctoral fellows, Domenica Berardi, PhD, and Na-Young Rho, PhD, have been awarded $25,000 grants for their projects investigating colorectal cancer in women and ovarian aging respectively.

Whether developing a new test for malaria, exposing health risks associated with climate change, or highlighting the impact of stigma on LGBTQ+ population well-being, Yale School of Public Health faculty advanced science in a variety of impactful ways over the past year.

A groundbreaking new database could lead to vast improvements in precision oncology by documenting sex-based differences in cancer treatment efficacy, biomarkers, risk factors, and microbial influences across 71 cancer types. The database — created by researchers at the Yale School of Public Health, Yale School of Medicine, and international collaborators — addresses a significant gap in current research and demonstrates how biological sex can comprehensively impact cancer onset, progression, and therapeutic outcomes.

A new study from the Yale School of Public Health (YSPH) offers fresh insights into our understanding of colorectal cancer (CRC) that challenge the conventional right-sided and left-sided classifications of the disease.

In a new study by researchers at the Yale School of Public Health, two “forever chemicals” spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis in living organisms.

Colon cancers that spread to the liver may be substantially different depending on the location where cancerous cells originate, according to new research.

Yale researchers identify diet-related metabolites associated with paraben concentrations in the urine of pregnant women. Parabens can disrupt endocrine activity in the body and they have been associated with changes in fertility in women.

Around 40% of colorectal cancer patients have a particular gene mutation. A new study shows it’s linked to reduced cell death and worse survival rates in men.